Search results
Can Moderna (MRNA) Diversify Beyond Its COVID-19 Jab Sales?
Zacks via Yahoo Finance· 10 months agoWith COVID-19 vaccine sales declining, Moderna (MRNA) is accelerating the development of its...
Vaccines Helped to Control COVID-19. But the Global Rollout Is Still Broken
Time via Yahoo News· 2 years agoA Kenyan health worker receives a dose of the Oxford/AstraZeneca vaccine, part of the COVAX...
Hitting the Books: How Moderna dialed-in its vaccine to fight COVID's variants
Engadget· 2 years agoIn "The Messenger," veteran reporter Peter Loftus takes readers through the harrowing days of 2020...
Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial
Press Association News via AOL· 1 year agoA High Court battle between rival developers of Covid-19 jabs over patents for vaccine technology is...
Moderna tops 1Q forecasts; vaccine sales plunge as expected
Associated Press via Yahoo News· 1 year agoSales of Moderna’s COVID-19 vaccine plunged in the first quarter and some expenses soared, but Wall...
Moderna stock plunges following mixed analyst reviews of cancer vaccine data
Yahoo Finance· 1 year agoModerna's (MRNA) stock dropped Monday despite positive news over the weekend from a Phase 2 trial of...
Can Moderna's (MRNA) Launches Reduce COVID Sales Dependency?
Zacks via Yahoo Finance· 5 months agoWith COVID-19 vaccine sales declining, Moderna (MRNA) is accelerating the development of its...
Moderna's Flu Vaccine Struggles: Is Novavax Stock Now a Better Buy?
Motley Fool· 1 year agoModerna (NASDAQ: MRNA) knows that it needs new products. The good news is that Moderna has three...
Decoding Moderna Inc (MRNA): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 months agoModerna Inc (NASDAQ:MRNA) faces a significant decrease in revenue and net income, reflecting a 91%...
Moderna (MRNA) Starts Early-Stage Nipah Virus Vaccine Study
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) doses the first participant in the phase I study of its investigational mRNA vaccine,...